Form D · Other
ASCEND ADVANCED THERAPIES GROUP, INC.
Alachua, FL · CIK 0002045430
Offering snapshot reported Nov 21, 2024 · SEC filing
- Reported sold
- $131M Offering amount: $131M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 21, 2024 | Initial | $130,574,171 | No comparison | 9 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-530130
Source: Form D, filed Nov 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Beecham | Director |
| Fred Cohen | Director |
| Timothy Funnell | Director |
| William Hawkins | Executive |
| Evis Hursever | Executive |
| Justin Kern | Director |
| Andrew Kozlov | Director |
| Wesley Mc Connell | Executive |
| Balaji Muralidhar | Director |
| Andrew Sinclair | Director |
| Michael Stella | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
14193 Nw 119 Th Terrace Suite 10
Alachua, FL, 32615
Alachua, FL, 32615